SCHEMBL3348708

SCHEMBL3348708

Cc1ccc(-c2nnnn2C)cc1N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.50
RAB9A P51151 3/20 0.42
TSHR P16473 3/20 0.42
HSD17B10 Q99714 1/20 0.42
KMO O15229 1/20 0.41
ALDH1A1 P00352 6/20 0.41
KDM4E B2RXH2 3/20 0.41
MAPT P10636 2/20 0.41
NPC1 O15118 2/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
KMT2A Q03164 2/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
TDP1 Q9NUW8 2/20 0.39
CASP1 P29466 1/20 0.39
ABCC9 O60706 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4872992 0.82 SMN1; SMN2 (0.46) SMN1; SMN2KMOALDH1A1KMT2ACYP2C9
SCHEMBL6278071 0.80 SMN1; SMN2 (0.56) SMN1; SMN2TSHRKMOALDH1A1MAPT
SCHEMBL23023473 0.79 PPM1B (0.47) SMN1; SMN2HSD17B10KMOALDH1A1KDM4E
SCHEMBL3375138 0.78 SMN1; SMN2 (0.52) SMN1; SMN2RAB9AHSD17B10KMOALDH1A1
SCHEMBL30132245 0.78 ALDH1A1 (0.56) SMN1; SMN2RAB9ATSHRHSD17B10KMO
SCHEMBL21388380 0.78 SMN1; SMN2 (0.45) SMN1; SMN2KMOALDH1A1MAPTKMT2A
SCHEMBL15508028 0.78 ALDH1A1 (0.56) SMN1; SMN2RAB9ATSHRHSD17B10KMO
Hydrochloric Acid SCHEMBL23270620 0.77 SMN1; SMN2 (0.50) SMN1; SMN2RAB9AHSD17B10KMOALDH1A1
SCHEMBL3348705 0.76 SMN1; SMN2 (0.44) SMN1; SMN2KMOALDH1A1KMT2ACYP2C9
SCHEMBL6608811 0.76 SMN1; SMN2 (0.50) SMN1; SMN2KMOALDH1A1KMT2ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 SMN1; SMN2 2819/4885RAB9A 1850/4885TSHR 1051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.